RBM20
Basic information
Region (hg38): 10:110644336-110839471
Links
Phenotypes
GenCC
Source:
- familial isolated dilated cardiomyopathy (Supportive), mode of inheritance: AD
- dilated cardiomyopathy 1DD (Strong), mode of inheritance: AD
- dilated cardiomyopathy 1DD (Definitive), mode of inheritance: AD
- dilated cardiomyopathy 1DD (Strong), mode of inheritance: AD
- hypertrophic cardiomyopathy (Limited), mode of inheritance: AD
- dilated cardiomyopathy (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cardiomyopathy, dilated, 1DD | AD | Cardiovascular | Surveillance (eg, with echocardiography and electrocardiography), preventive measures and medical management may help decrease morbidity; Cardiac transplantation has been described | Cardiovascular | 19712804; 20590677; 21846512 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
- Dilated cardiomyopathy 1DD (3 variants)
- Cardiovascular phenotype (2 variants)
- RBM20-related disorder (1 variants)
- Cardiomyopathy (1 variants)
- Dilated cardiomyopathy 1S (1 variants)
- Primary dilated cardiomyopathy (1 variants)
- Dilated cardiomyopathy 1A (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RBM20 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 384 | 402 | |||
missense | 650 | 86 | 13 | 761 | ||
nonsense | 32 | 35 | ||||
start loss | 0 | |||||
frameshift | 41 | 44 | ||||
inframe indel | 26 | 26 | ||||
splice donor/acceptor (+/-2bp) | 10 | 10 | ||||
splice region | 15 | 33 | 1 | 49 | ||
non coding | 63 | 116 | 49 | 228 | ||
Total | 5 | 12 | 834 | 587 | 68 |
Variants in RBM20
This is a list of pathogenic ClinVar variants found in the RBM20 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-110644424-T-C | Dilated cardiomyopathy 1DD | Uncertain significance (Jan 12, 2018) | ||
10-110644436-C-T | not specified | Likely benign (Jan 26, 2016) | ||
10-110644439-G-T | not specified | Uncertain significance (Feb 16, 2015) | ||
10-110644447-C-T | not specified | Likely benign (Dec 27, 2017) | ||
10-110644449-C-T | not specified | Likely benign (Oct 27, 2022) | ||
10-110644453-G-T | Cardiovascular phenotype | Uncertain significance (Oct 04, 2021) | ||
10-110644454-C-T | Cardiovascular phenotype | Uncertain significance (Mar 28, 2020) | ||
10-110644458-G-T | Cardiomyopathy | Uncertain significance (Nov 27, 2019) | ||
10-110644459-T-C | Dilated cardiomyopathy 1DD • Cardiomyopathy | Uncertain significance (Aug 03, 2022) | ||
10-110644461-C-T | Dilated cardiomyopathy 1DD • Cardiovascular phenotype | Likely benign (Jan 22, 2024) | ||
10-110644468-C-T | Dilated cardiomyopathy 1DD • Cardiovascular phenotype | Conflicting classifications of pathogenicity (Apr 19, 2024) | ||
10-110644469-A-T | Dilated cardiomyopathy 1DD • Cardiovascular phenotype | Likely benign (Sep 30, 2023) | ||
10-110644470-G-A | Dilated cardiomyopathy 1DD • Cardiovascular phenotype | Uncertain significance (Mar 14, 2024) | ||
10-110644473-A-G | Uncertain significance (May 30, 2024) | |||
10-110644473-A-T | Uncertain significance (Dec 05, 2017) | |||
10-110644474-T-C | Cardiovascular phenotype | Uncertain significance (Dec 05, 2019) | ||
10-110644474-T-G | Dilated cardiomyopathy 1DD | Likely benign (Sep 17, 2022) | ||
10-110644479-C-T | Dilated cardiomyopathy 1DD | Uncertain significance (Dec 06, 2021) | ||
10-110644481-G-C | Dilated cardiomyopathy 1DD • Cardiovascular phenotype | Conflicting classifications of pathogenicity (May 22, 2024) | ||
10-110644486-C-T | Uncertain significance (Mar 05, 2015) | |||
10-110644489-A-T | Dilated cardiomyopathy 1DD | Uncertain significance (Sep 15, 2023) | ||
10-110644490-C-A | Cardiovascular phenotype • Dilated cardiomyopathy 1DD | Conflicting classifications of pathogenicity (Dec 27, 2023) | ||
10-110644490-C-T | Cardiovascular phenotype | Likely benign (Oct 26, 2023) | ||
10-110644496-C-G | Dilated cardiomyopathy 1DD • Cardiovascular phenotype | Conflicting classifications of pathogenicity (Nov 06, 2023) | ||
10-110644497-G-A | Dilated cardiomyopathy 1DD • Cardiovascular phenotype | Uncertain significance (Jan 27, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RBM20 | protein_coding | protein_coding | ENST00000369519 | 14 | 195073 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.990 | 0.0105 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.67 | 543 | 664 | 0.818 | 0.0000376 | 7995 |
Missense in Polyphen | 184 | 246.54 | 0.74633 | 2879 | ||
Synonymous | 2.10 | 226 | 270 | 0.837 | 0.0000165 | 2450 |
Loss of Function | 5.22 | 7 | 44.6 | 0.157 | 0.00000218 | 575 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: RNA-binding protein that acts as a regulator of mRNA splicing of a subset of genes involved in cardiac development. Regulates splicing of TTN (Titin). {ECO:0000269|PubMed:22466703}.;
Intolerance Scores
- loftool
- rvis_EVS
- 1.02
- rvis_percentile_EVS
- 90.98
Haploinsufficiency Scores
- pHI
- 0.359
- hipred
- hipred_score
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.140
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rbm20
- Phenotype
- homeostasis/metabolism phenotype; muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- mRNA processing;heart development;RNA splicing;positive regulation of RNA splicing
- Cellular component
- nucleus
- Molecular function
- RNA binding;zinc ion binding